Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Antibacterial activity against Haemophilus influenzae assessed as inhibition of bacterial growth
Assay data:1 Active, 1 Activity ≤ 1 µM, 1 Tested
SummaryCompounds, ActiveCompounds, activity ≤ 1 µMPubMed Citation
Inhibition of Haemophilus influenzae DapE
Assay data:5 Tested
SummaryPubMed CitationRelated BioAssays by Target
Antibacterial activity against Haemophilus influenzae assessed as reduction in bacterial growth by broth microdilution method
Assay data:3 Active, 4 Tested
SummaryCompounds, ActivePubMed Citation
Inhibition of Haemophilus influenzae ATCC 51907 FabI assessed as by measuring NADH consumption rate
Assay data:2 Active, 1 Activity ≤ 1 µM, 2 Tested
Antibacterial activity against Haemophilus influenzae
Assay data:1 Tested
SummaryPubMed Citation
Antibacterial activity against Haemophilus influenzae assessed as bacterial growth inhibition incubated for 24 hrs by micro-broth dilution method
Inhibition of Haemophilus influenzae DapE at 75 uM relative to control
Inhibition of Haemophilus influenzae DapE at 100 uM relative to control
Assay data:13 Tested
Antibacterial activity against wild type Haemophilus influenzae incubated for 20 hrs by two-fold serial dilution method
Assay data:3 Tested
Antibacterial activity against Haemophilus influenzae ATCC 49247 assessed as inhibition of bacterial growth
Assay data:15 Tested
Antibacterial activity against Haemophilus influenzae assessed as bacterial growth inhibition by CLSI based broth microdilution method
Assay data:2 Tested
Antibacterial activity against Haemophilus influenzae ATCC 49247 by microbroth dilution method
Assay data:26 Tested
Antibacterial activity against Haemophilus influenzae pneumoniae ATCC 35054 incubated for 18 hrs by CLSI protocol based two-fold serial agar dilution method
Assay data:29 Tested
Inhibition of Haemophilus influenza HmrM transporter expressed in Escherichia coli KAM32 assessed as inhibition of bacterial resistance to norfloxacin by measuring reduction in bacterial growth at 100 uM incubated for 18 hrs by microbroth dilution method (Rvb = 0%)
Assay data:20 Tested
Inhibition of Haemophilus influenza HmrM transporter expressed in Escherichia coli KAM32 assessed as inhibition of bacterial resistance to norfloxacin by measuring norfloxacin MIC at 100 uM incubated for 18 hrs by microbroth dilution method (Rvb = 64 ng/ml)
Inhibition of Haemophilus influenzae PBP3 assessed as residual activity at 1 mM preincubated for 1 hr followed by substrate addition measured after 30 mins by fluorescence anisotropy assay relative to control
Antimicrobial activity against Haemophilus influenzae ATCC 49766 assessed as bacterial growth inhibition incubated for 18 hrs by CLSI protocol based broth microdilution method
Antibacterial activity against Haemophilus influenzae ARC737 by broth microdilution method
Assay data:26 Active, 15 Activity ≤ 1 µM, 26 Tested
Inhibition of Haemophilus influenzae Rd IGA1 protease expressed in Escherichia coli BL21(DE3) preincubated for 1 hr followed by substrate addition and measured after 2 hrs by sandwich ELISA
Assay data:2 Active, 2 Tested
SummaryCompounds, ActivePubMed CitationRelated BioAssays by Target
Antibacterial activity against Haemophilus influenzae ATCC 43095 by CLSI method
Assay data:12 Tested
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on